Our dermatology products showed significant growth in 2006 led by our key products, Kinerase^® and Efudex^®. Our dermatology products help patients who are suffering from actinic keratosis, skin cancer and severe psoriasis and those who are looking for a reduction in the appearance of scars, skin aging and apparent pigmentation.

Valeant's dermatology franchise offers a number of topical dermatological products globally. Kinerase and Efudex/Efudix are key focuses for Valeant, but a number of other successful brands are promoted in markets throughout the world, including Dermatix^®, Glyquin^®, Solaquin^® and Eldoquin^®.

Efudex Safety and Prescribing Information

Efudex is contraindicated in women who are, or may become, pregnant during therapy because of potential hazards to the fetus. Cases of miscarriage and birth defects have been reported in women who are pregnant. The most frequent adverse events occur locally and may include itching, burning, soreness, tenderness, rash, scaling, scarring, photosensitivity, and swelling. Application to mucous membranes should be avoided due to the possibility of local inflammation and ulceration.

Please click here for important safety information and complete prescribing information for Efudex.